Legal & General Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Legal & General Group’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-16,600	Closed	-$717K	–	2817
2015 Q3	$717K	Sell	16,600 -4,700	-22%	-$198K	﹤0.01%	1207
2015 Q2	$900K	Hold	21,300	–	–	﹤0.01%	1170
2015 Q1	$826K	Hold	21,300	–	–	﹤0.01%	1165
2014 Q4	$717K	Hold	21,300	–	–	﹤0.01%	1169
2014 Q3	$746K	Hold	21,300	–	–	﹤0.01%	1114
2014 Q2	$700K	Hold	21,300	–	–	﹤0.01%	1097
2014 Q1	$785K	Sell	21,300 -2,000	-9%	-$73.4K	﹤0.01%	1038
2013 Q4	$894K	Buy	23,300 +5,300	+29%	+$167K	﹤0.01%	998
2013 Q3	$493K	Hold	18,000	–	–	﹤0.01%	1113
2013 Q2	$378K	Buy	+18,000	New	+$351K	﹤0.01%	1100

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Legal & General Group's WX Position: Q4 2015 in Review

Legal & General Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 16,600 shares — an estimated $717K sold.

Legal & General Group first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $900K in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Legal & General Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Legal & General Group sold 16,600 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $717K.
Legal & General Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
Legal & General Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $900K in Q2 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Legal & General Group's 13F filing for Q4 2015, filed 16 Feb 2016.